The association between HLA‐DPB1Glu69 and chronic beryllium disease and beryllium sensitization
Authors:
- 19 July 2004
- journal article
- research article
- Published by Wiley in American Journal of Industrial Medicine
- Vol. 46 (2) , 95-103
Abstract
Background: Several case‐control studies have found an association between chronic beryllium disease (CBD) and HLA‐DPB1 gene variants. However, the relationship between HLA‐DPB1 and beryllium sensitization, and whether the presence of one or two HLA‐DPB1Glu69 alleles is differentially associated with CBD and beryllium sensitization have not been completely resolved.Methods: Restriction fragment length polymorphism (RFLP) analysis was used to address these questions in a large population‐based cohort consisting of 884 beryllium workers (90 with CBD, 64 beryllium sensitized).Results: HLA‐DPB1Glu69 was associated with both CBD (OR = 9.4; 95% CI = 5.4, 16.6) and sensitization (OR = 3.3, 95% CI = 1.9, 5.9). Further, workers with CBD and sensitization were more likely to be homozygous HLA‐DPB1Glu69 compared to workers without disease or sensitization (P < 0.001).Conclusions: Follow‐up of this cohort, scrutiny of HLA‐DPB1 haplotypes, and evaluation of gene–environment and gene–gene interactions will be important for fully understanding the immunogenetic nature of this occupational disease. Am. J. Ind. Med. 46:95–103, 2004. Published 2004 Wiley‐Liss, Inc.Keywords
This publication has 23 references indexed in Scilit:
- Electrostatic potential on human leukocyte antigen: implications for putative mechanism of chronic beryllium disease.Environmental Health Perspectives, 2003
- Racial differences in prevalence of a supratypic HLA‐genetic marker immaterial to pre‐employment testing for susceptibility to chronic beryllium diseaseAmerican Journal of Industrial Medicine, 2002
- Major histocompatibility locus genetic markers of beryllium sensitization and diseaseEuropean Respiratory Journal, 2001
- Variability, Predictive Value, and Uses of the Beryllium Blood Lymphocyte Proliferation Test (BLPT): Preliminary Analysis of the Ongoing Workforce SurveyApplied Occupational and Environmental Hygiene, 2001
- Interaction of genetic and exposure factors in the prevalence of berylliosisAmerican Journal of Industrial Medicine, 1997
- The role of HLA-DPβ residue 69 in the definition of antibody-binding epitopesHuman Immunology, 1995
- HLA-DPB1 Glutamate 69: a Genetic Marker of Beryllium DiseaseScience, 1993
- Screening Blood Test Identifies Subclinical Beryllium DiseaseJournal of Occupational and Environmental Medicine, 1989
- Maintenance of Alveolitis in Patients with Chronic Beryllium Disease by Beryllium-Specific Helper T CellsNew England Journal of Medicine, 1989
- Development of Beryllium Lymphocyte Transformation Tests in Chronic Beryllium DiseaseInternational Archives of Allergy and Immunology, 1982